For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Aegis Therapeutics, LLC

USPTO Granted Patents = 35

EPO Patents = 3

Trademarks = 3

Forward Citations = 429

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Edward T Maggio (35 out of 53 patents)

Pratik Shah (6 out of 17 patents)

Richard Lowenthal (6 out of 8 patents)

4. Robert G Bell (6 out of 16 patents)

5. Dennis J Pillion (2 out of 4 patents)

6. Sarah L Morgan (2 out of 2 patents)

7. Joe Baggott (2 out of 2 patents)

8. Roger Crystal (1 out of 10 patents)

9. Steve Cartt (1 out of 15 patents)

10. David Medeiros (1 out of 10 patents)

11. Elis Meezan (1 out of 1 patent)

12. Elias Meezan (1 out of 5 patents)

Core Competencies:

Intranasal Epinephrine

Opioid Overdose

Drug Administration

Absorption Enhancers

Pharmaceutical Composition

Controlled Release

Alkyl Glycoside

Antibacterial Compositions

Active Agents

Multimodal Formulations

Stabilizing Compositions

35 patents: Sort by Forward Citations

1. 12324838 - Intranasal epinephrine formulations and methods for the treatment of disease (2025-06-10),

2. 11918655 - Intranasal epinephrine formulations and methods for the treatment of disease (2024-03-05),

3. 11744895 - Intranasal epinephrine formulations and methods for the treatment of disease (2023-09-05),

4. 11717571 - Intranasal epinephrine formulations and methods for the treatment of disease (2023-08-08),

5. 11458091 - Compositions and methods for the treatment of opioid overdose (2022-10-04),

6. 11191838 - Intranasal epinephrine formulations and methods for the treatment of disease (2021-12-07),

7. 11173209 - Compositions for drug administration (2021-11-16),

8. 10682414 - Intranasal epinephrine formulations and methods for the treatment of disease (2020-06-16),

9. 10576156 - Compositions for drug administration (2020-03-03),

10. 10512694 - Compositions for oral drug administration (2019-12-24),

11. 10265402 - Absorption enhancers for drug administration (2019-04-23),

12. 10046025 - Stabilizing alkylglycoside compositions and methods thereof (2018-08-14),

13. 9895444 - Compositions for drug administration (2018-02-20),

14. 9642913 - Pharmaceutical composition including alkyl glycoside and an anti-seizure agent (2017-05-09),

15. 9446134 - Stabilizing alkylglycoside compositions and methods thereof (2016-09-20),

Company Overview

Aegis Therapeutics, LLC is a biotechnology company based in San Diego, California, specializing in the development of innovative drug delivery technologies. The company focuses on enhancing the bioavailability and therapeutic efficacy of pharmaceutical compounds through its proprietary formulations. Aegis Therapeutics is dedicated to advancing healthcare solutions by leveraging its expertise in drug delivery systems, aiming to improve patient outcomes and streamline the treatment process across various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

35 Patents

#178 in San Diego, CA

#2,308 in California

#9,749 in US

#19,168 in the World

San Diego, CA, United States of America

Aegis Therapeutics, LLC

Forward Citations = 429

12 inventors:

Edward T Maggio (35 out of 53 patents)

Pratik Shah (6 out of 17 patents)

Richard Lowenthal (6 out of 8 patents)

4. Robert G Bell (6 out of 16 patents)

5. Dennis J Pillion (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aegis Therapeutics, LLC. Retrieved from https://idiyas.com/company/aegis-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…